Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Journal of Alzheimer'S Disease Reports|October 22, 2024
The Effect of FTY720 on Sphingolipid Imbalance and Cognitive Decline in Aged EFAD MiceQian Luo, Simone M Crivelli, Shenghua Zong, et al.
British Journal of Haematology|February 19, 2020
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivityEsther Onecha, Yanira Ruiz-Heredia, David Martínez-Cuadrón, et al.
Journal of Autoimmunity|January 21, 2014
Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptorKathleen Vrolix, Judith Fraussen, Mario Losen, et al.
Neuromuscular Disorders : NMD|April 10, 2023
Outcomes after robotic thymectomy in nonthymomatous versus thymomatous patients with acetylcholine-receptor-antibody-associated myasthenia gravisFlorit Marcuse, Janneke G J Hoeijmakers, Monique Hochstenbag, et al.
Frontiers in Aging Neuroscience|November 15, 2021
Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control MiceSandra den Hoedt, Simone M Crivelli, Frank P J Leijten, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2022
FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4Simone M Crivelli, Qian Luo, Daan van Kruining, et al.
Pageof 20